Unresolved disorder model. using A ATOM 41 CA AGLN 6 5.267 -32.950 -3.755 0.50 23.67 C Unresolved disorder model. using A ATOM 42 CA BGLN 6 5.257 -32.942 -3.750 0.50 26.00 C Unresolved disorder model. using A ATOM 45 CB AGLN 6 5.155 -32.422 -5.191 0.50 21.67 C Unresolved disorder model. using A ATOM 46 CB BGLN 6 5.102 -32.371 -5.166 0.50 26.87 C Unresolved disorder model. using A ATOM 47 CG AGLN 6 5.352 -33.523 -6.257 0.50 22.48 C Unresolved disorder model. using A ATOM 48 CG BGLN 6 4.619 -33.368 -6.205 0.50 34.18 C Unresolved disorder model. using A ATOM 49 CD AGLN 6 4.127 -34.389 -6.411 0.50 23.13 C Unresolved disorder model. using A ATOM 50 CD BGLN 6 3.802 -32.697 -7.313 0.50 37.99 C Unresolved disorder model. using A ATOM 51 OE1AGLN 6 4.193 -35.647 -6.302 0.50 26.55 O Unresolved disorder model. using A ATOM 52 OE1BGLN 6 3.097 -31.708 -7.077 0.50 46.22 O Unresolved disorder model. using A ATOM 53 NE2AGLN 6 2.975 -33.733 -6.641 0.50 18.48 N Unresolved disorder model. using A ATOM 54 NE2BGLN 6 3.888 -33.235 -8.518 0.50 41.97 N Unresolved disorder model. using A ATOM 147 N AVAL 19 13.413 -36.175 -3.736 0.60 19.73 N Unresolved disorder model. using A ATOM 148 N BVAL 19 13.441 -36.145 -3.737 0.40 21.92 N Unresolved disorder model. using A ATOM 149 CA AVAL 19 13.223 -34.729 -3.791 0.60 21.74 C Unresolved disorder model. using A ATOM 150 CA BVAL 19 13.298 -34.704 -3.640 0.40 24.22 C Unresolved disorder model. using A ATOM 151 C AVAL 19 11.851 -34.364 -3.199 0.60 23.20 C Unresolved disorder model. using A ATOM 152 C BVAL 19 11.891 -34.369 -3.178 0.40 23.94 C Unresolved disorder model. using A ATOM 153 O AVAL 19 10.853 -35.038 -3.485 0.60 23.09 O Unresolved disorder model. using A ATOM 154 O BVAL 19 10.920 -35.053 -3.528 0.40 24.07 O Unresolved disorder model. using A ATOM 155 CB AVAL 19 13.314 -34.223 -5.260 0.60 20.70 C Unresolved disorder model. using A ATOM 156 CB BVAL 19 13.563 -34.033 -4.990 0.40 24.95 C Unresolved disorder model. using A ATOM 157 CG1AVAL 19 12.943 -32.691 -5.396 0.60 19.59 C Unresolved disorder model. using A ATOM 158 CG1BVAL 19 12.531 -34.469 -5.928 0.40 27.44 C Unresolved disorder model. using A ATOM 159 CG2AVAL 19 14.695 -34.593 -5.911 0.60 17.43 C Unresolved disorder model. using A ATOM 160 CG2BVAL 19 13.533 -32.496 -4.887 0.40 25.10 C Unresolved disorder model. using A ATOM 166 N AVAL 21 9.419 -31.000 -3.263 0.50 21.78 N Unresolved disorder model. using A ATOM 167 N BVAL 21 9.451 -30.998 -3.296 0.50 22.27 N Unresolved disorder model. using A ATOM 168 CA AVAL 21 9.239 -29.656 -3.858 0.50 19.82 C Unresolved disorder model. using A ATOM 169 CA BVAL 21 9.337 -29.638 -3.849 0.50 19.92 C Unresolved disorder model. using A ATOM 170 C AVAL 21 8.099 -28.946 -3.148 0.50 19.32 C Unresolved disorder model. using A ATOM 171 C BVAL 21 8.123 -28.934 -3.217 0.50 19.57 C Unresolved disorder model. using A ATOM 172 O AVAL 21 7.019 -29.526 -2.968 0.50 19.70 O Unresolved disorder model. using A ATOM 173 O BVAL 21 7.040 -29.530 -3.103 0.50 19.73 O Unresolved disorder model. using A ATOM 174 CB AVAL 21 8.784 -29.751 -5.306 0.50 21.49 C Unresolved disorder model. using A ATOM 175 CB BVAL 21 9.253 -29.645 -5.391 0.50 22.38 C Unresolved disorder model. using A ATOM 176 CG1AVAL 21 8.689 -28.342 -5.951 0.50 21.21 C Unresolved disorder model. using A ATOM 177 CG1BVAL 21 8.056 -30.460 -5.880 0.50 19.64 C Unresolved disorder model. using A ATOM 178 CG2AVAL 21 9.704 -30.659 -6.073 0.50 18.41 C Unresolved disorder model. using A ATOM 179 CG2BVAL 21 9.202 -28.199 -5.942 0.50 21.18 C Unresolved disorder model. using A ATOM 247 CA AGLU 31 18.823 -36.508 -0.498 0.50 20.32 C Unresolved disorder model. using A ATOM 248 CA BGLU 31 18.810 -36.498 -0.496 0.50 22.00 C Unresolved disorder model. using A ATOM 251 CB AGLU 31 18.419 -37.087 0.884 0.50 19.75 C Unresolved disorder model. using A ATOM 252 CB BGLU 31 18.312 -37.075 0.833 0.50 23.53 C Unresolved disorder model. using A ATOM 253 CG AGLU 31 17.265 -38.124 0.892 0.50 18.64 C Unresolved disorder model. using A ATOM 254 CG BGLU 31 18.092 -36.047 2.006 0.50 27.26 C Unresolved disorder model. using A ATOM 255 CD AGLU 31 16.948 -38.850 2.260 0.50 19.03 C Unresolved disorder model. using A ATOM 256 CD BGLU 31 19.367 -35.346 2.432 0.50 30.49 C Unresolved disorder model. using A ATOM 257 OE1AGLU 31 17.301 -38.431 3.377 0.50 14.54 O Unresolved disorder model. using A ATOM 258 OE1BGLU 31 20.406 -35.993 2.244 0.50 31.49 O Unresolved disorder model. using A ATOM 259 OE2AGLU 31 16.255 -39.899 2.204 0.50 22.57 O Unresolved disorder model. using A ATOM 260 OE2BGLU 31 19.364 -34.167 2.896 0.50 25.67 O Unresolved disorder model. using A ATOM 288 N AGLU 36 14.629 -46.427 -2.981 0.50 29.69 N Unresolved disorder model. using A ATOM 289 N BGLU 36 14.697 -46.339 -3.022 0.50 30.11 N Unresolved disorder model. using A ATOM 290 CA AGLU 36 13.438 -45.744 -2.384 0.50 29.45 C Unresolved disorder model. using A ATOM 291 CA BGLU 36 13.510 -45.843 -2.367 0.50 31.06 C Unresolved disorder model. using A ATOM 292 C AGLU 36 12.458 -46.608 -1.583 0.50 28.29 C Unresolved disorder model. using A ATOM 293 C BGLU 36 12.919 -47.023 -1.644 0.50 28.08 C Unresolved disorder model. using A ATOM 294 O AGLU 36 11.399 -46.967 -2.069 0.50 31.07 O Unresolved disorder model. using A ATOM 295 O BGLU 36 12.690 -48.080 -2.249 0.50 29.00 O Unresolved disorder model. using A ATOM 296 CB AGLU 36 12.648 -44.936 -3.433 0.50 25.77 C Unresolved disorder model. using A ATOM 297 CB BGLU 36 12.536 -45.240 -3.370 0.50 30.48 C Unresolved disorder model. using A ATOM 298 CG AGLU 36 11.501 -44.152 -2.773 0.50 29.04 C Unresolved disorder model. using A ATOM 299 CG BGLU 36 11.558 -44.289 -2.719 0.50 36.58 C Unresolved disorder model. using A ATOM 300 CD AGLU 36 10.541 -43.470 -3.759 0.50 31.18 C Unresolved disorder model. using A ATOM 301 CD BGLU 36 10.721 -43.572 -3.750 0.50 41.19 C Unresolved disorder model. using A ATOM 302 OE1AGLU 36 9.988 -44.122 -4.685 0.50 27.46 O Unresolved disorder model. using A ATOM 303 OE1BGLU 36 10.878 -43.873 -4.951 0.50 38.35 O Unresolved disorder model. using A ATOM 304 OE2AGLU 36 10.270 -42.270 -3.550 0.50 25.39 O Unresolved disorder model. using A ATOM 305 OE2BGLU 36 9.895 -42.719 -3.360 0.50 44.17 O Unresolved disorder model. using A ATOM 387 CA ALYS 47 13.268 -34.283 8.446 0.50 17.46 C Unresolved disorder model. using A ATOM 388 CA BLYS 47 13.255 -34.278 8.484 0.50 19.18 C Unresolved disorder model. using A ATOM 391 CB ALYS 47 14.466 -34.670 7.561 0.50 16.04 C Unresolved disorder model. using A ATOM 392 CB BLYS 47 14.532 -34.662 7.720 0.50 21.12 C Unresolved disorder model. using A ATOM 393 CG ALYS 47 15.335 -35.745 8.185 0.50 17.96 C Unresolved disorder model. using A ATOM 394 CG BLYS 47 15.491 -35.504 8.568 0.50 25.95 C Unresolved disorder model. using A ATOM 395 CD ALYS 47 16.642 -35.943 7.390 0.50 15.80 C Unresolved disorder model. using A ATOM 396 CD BLYS 47 16.781 -35.888 7.785 0.50 29.14 C Unresolved disorder model. using A ATOM 397 CE ALYS 47 16.429 -36.642 6.096 0.50 14.71 C Unresolved disorder model. using A ATOM 398 CE BLYS 47 17.785 -34.742 7.787 0.50 34.25 C Unresolved disorder model. using A ATOM 399 NZ ALYS 47 17.730 -36.648 5.306 0.50 19.96 N Unresolved disorder model. using A ATOM 400 NZ BLYS 47 19.020 -34.982 6.946 0.50 40.94 N Unresolved disorder model. using A ATOM 474 CA AVAL 57 2.353 -34.151 0.808 0.50 22.77 C Unresolved disorder model. using A ATOM 475 CA BVAL 57 2.386 -34.229 0.878 0.50 22.42 C Unresolved disorder model. using A ATOM 478 CB AVAL 57 3.531 -34.892 1.446 0.50 21.65 C Unresolved disorder model. using A ATOM 479 CB BVAL 57 3.416 -35.097 1.677 0.50 21.46 C Unresolved disorder model. using A ATOM 480 CG1AVAL 57 3.018 -36.152 2.113 0.50 19.20 C Unresolved disorder model. using A ATOM 481 CG1BVAL 57 4.254 -36.066 0.786 0.50 20.45 C Unresolved disorder model. using A ATOM 482 CG2AVAL 57 4.617 -35.223 0.388 0.50 22.83 C Unresolved disorder model. using A ATOM 483 CG2BVAL 57 4.319 -34.202 2.562 0.50 17.52 C Unresolved disorder model. using A ATOM 484 N AHIS 58 1.952 -34.719 -1.485 0.70 23.38 N Unresolved disorder model. using A ATOM 485 N BHIS 58 1.974 -34.686 -1.481 0.30 22.91 N Unresolved disorder model. using A ATOM 486 CA AHIS 58 1.533 -35.592 -2.583 0.70 26.81 C Unresolved disorder model. using A ATOM 487 CA BHIS 58 1.605 -35.505 -2.634 0.30 23.70 C Unresolved disorder model. using A ATOM 488 C AHIS 58 2.661 -36.567 -2.823 0.70 24.12 C Unresolved disorder model. using A ATOM 489 C BHIS 58 2.703 -36.563 -2.799 0.30 22.97 C Unresolved disorder model. using A ATOM 490 O AHIS 58 3.765 -36.167 -3.243 0.70 24.74 O Unresolved disorder model. using A ATOM 491 O BHIS 58 3.833 -36.221 -3.166 0.30 23.71 O Unresolved disorder model. using A ATOM 492 CB AHIS 58 1.201 -34.784 -3.855 0.70 28.47 C Unresolved disorder model. using A ATOM 493 CB BHIS 58 1.497 -34.625 -3.900 0.30 22.48 C Unresolved disorder model. using A ATOM 494 CG AHIS 58 -0.040 -33.953 -3.719 0.70 36.58 C Unresolved disorder model. using A ATOM 495 CG BHIS 58 0.484 -33.516 -3.796 0.30 23.46 C Unresolved disorder model. using A ATOM 496 ND1AHIS 58 -1.311 -34.485 -3.806 0.70 38.31 N Unresolved disorder model. using A ATOM 497 ND1BHIS 58 0.373 -32.515 -4.741 0.30 23.05 N Unresolved disorder model. using A ATOM 498 CD2AHIS 58 -0.205 -32.637 -3.445 0.70 41.40 C Unresolved disorder model. using A ATOM 499 CD2BHIS 58 -0.448 -33.241 -2.851 0.30 24.28 C Unresolved disorder model. using A ATOM 500 CE1AHIS 58 -2.205 -33.533 -3.606 0.70 43.61 C Unresolved disorder model. using A ATOM 501 CE1BHIS 58 -0.607 -31.696 -4.404 0.30 23.53 C Unresolved disorder model. using A ATOM 502 NE2AHIS 58 -1.560 -32.400 -3.388 0.70 44.70 N Unresolved disorder model. using A ATOM 503 NE2BHIS 58 -1.114 -32.106 -3.252 0.30 24.48 N Unresolved disorder model. using A ATOM 505 CA ATHR 59 3.428 -38.879 -2.540 0.50 21.96 C Unresolved disorder model. using A ATOM 506 CA BTHR 59 3.403 -38.862 -2.508 0.50 22.34 C Unresolved disorder model. using A ATOM 509 CB ATHR 59 3.025 -40.196 -1.852 0.50 24.28 C Unresolved disorder model. using A ATOM 510 CB BTHR 59 2.878 -39.985 -1.628 0.50 27.41 C Unresolved disorder model. using A ATOM 511 OG1ATHR 59 1.747 -40.617 -2.332 0.50 24.11 O Unresolved disorder model. using A ATOM 512 OG1BTHR 59 2.387 -39.370 -0.421 0.50 27.83 O Unresolved disorder model. using A ATOM 513 CG2ATHR 59 3.013 -40.043 -0.320 0.50 26.47 C Unresolved disorder model. using A ATOM 514 CG2BTHR 59 3.944 -40.989 -1.255 0.50 25.72 C Unresolved disorder model. using A ATOM 665 CA ALYS 80 -1.934 -35.264 5.392 0.50 29.58 C Unresolved disorder model. using A ATOM 666 CA BLYS 80 -1.923 -35.240 5.379 0.50 29.79 C Unresolved disorder model. using A ATOM 669 CB ALYS 80 -3.072 -34.327 4.969 0.50 31.30 C Unresolved disorder model. using A ATOM 670 CB BLYS 80 -2.960 -34.239 4.901 0.50 30.68 C Unresolved disorder model. using A ATOM 671 CG ALYS 80 -4.220 -34.991 4.156 0.50 31.77 C Unresolved disorder model. using A ATOM 672 CG BLYS 80 -3.825 -33.696 5.998 0.50 32.72 C Unresolved disorder model. using A ATOM 673 CD ALYS 80 -5.143 -33.881 3.572 0.50 38.41 C Unresolved disorder model. using A ATOM 674 CD BLYS 80 -4.990 -32.946 5.377 0.50 39.59 C Unresolved disorder model. using A ATOM 675 CE ALYS 80 -6.275 -34.451 2.725 0.50 40.74 C Unresolved disorder model. using A ATOM 676 CE BLYS 80 -5.887 -32.420 6.455 0.50 42.41 C Unresolved disorder model. using A ATOM 677 NZ ALYS 80 -7.267 -35.157 3.597 0.50 42.65 N Unresolved disorder model. using A ATOM 678 NZ BLYS 80 -6.282 -31.085 6.001 0.50 41.25 N Unresolved disorder model. using A ATOM 710 CA AILE 85 -1.813 -38.233 -9.475 0.50 41.26 C Unresolved disorder model. using A ATOM 711 CA BILE 85 -1.793 -38.230 -9.479 0.50 49.17 C Unresolved disorder model. using A ATOM 714 CB AILE 85 -3.111 -39.039 -9.569 0.50 39.91 C Unresolved disorder model. using A ATOM 715 CB BILE 85 -3.000 -39.210 -9.661 0.50 56.14 C Unresolved disorder model. using A ATOM 716 CG1AILE 85 -2.956 -40.408 -8.890 0.50 29.70 C Unresolved disorder model. using A ATOM 717 CG1BILE 85 -3.852 -38.826 -10.875 0.50 60.38 C Unresolved disorder model. using A ATOM 718 CG2AILE 85 -3.532 -39.194 -11.047 0.50 37.27 C Unresolved disorder model. using A ATOM 719 CG2BILE 85 -3.890 -39.266 -8.448 0.50 56.34 C Unresolved disorder model. using A ATOM 720 CD1AILE 85 -4.264 -40.954 -8.289 0.50 31.93 C Unresolved disorder model. using A ATOM 721 CD1BILE 85 -3.198 -39.110 -12.178 0.50 63.41 C Unresolved disorder model. using A ATOM 848 N ALEU 102 17.633 -30.613 -12.599 0.70 37.17 N Unresolved disorder model. using A ATOM 849 N BLEU 102 17.591 -30.596 -12.601 0.30 28.82 N Unresolved disorder model. using A ATOM 850 CA ALEU 102 18.488 -30.987 -11.463 0.70 34.27 C Unresolved disorder model. using A ATOM 851 CA BLEU 102 18.380 -31.003 -11.441 0.30 24.95 C Unresolved disorder model. using A ATOM 852 C ALEU 102 19.682 -31.754 -11.945 0.70 32.56 C Unresolved disorder model. using A ATOM 853 C BLEU 102 19.606 -31.775 -11.901 0.30 25.84 C Unresolved disorder model. using A ATOM 854 O ALEU 102 20.849 -31.528 -11.527 0.70 25.20 O Unresolved disorder model. using A ATOM 855 O BLEU 102 20.721 -31.522 -11.433 0.30 24.81 O Unresolved disorder model. using A ATOM 856 CB ALEU 102 17.711 -31.876 -10.487 0.70 38.04 C Unresolved disorder model. using A ATOM 857 CB BLEU 102 17.522 -31.843 -10.476 0.30 19.68 C Unresolved disorder model. using A ATOM 858 CG ALEU 102 17.160 -31.141 -9.279 0.70 42.53 C Unresolved disorder model. using A ATOM 859 CG BLEU 102 18.196 -32.381 -9.205 0.30 14.94 C Unresolved disorder model. using A ATOM 860 CD1ALEU 102 16.193 -32.003 -8.484 0.70 41.01 C Unresolved disorder model. using A ATOM 861 CD1BLEU 102 18.788 -31.280 -8.423 0.30 14.43 C Unresolved disorder model. using A ATOM 862 CD2ALEU 102 18.309 -30.601 -8.383 0.70 39.96 C Unresolved disorder model. using A ATOM 863 CD2BLEU 102 17.198 -33.131 -8.309 0.30 14.00 C Unresolved disorder model. using A ATOM 1279 CA AGLN 155 25.934 -21.027 15.467 0.60 23.10 C Unresolved disorder model. using A ATOM 1280 CA BGLN 155 25.934 -21.006 15.472 0.40 23.87 C Unresolved disorder model. using A ATOM 1283 CB AGLN 155 25.524 -20.704 16.903 0.60 22.17 C Unresolved disorder model. using A ATOM 1284 CB BGLN 155 25.553 -20.573 16.902 0.40 24.62 C Unresolved disorder model. using A ATOM 1285 CG AGLN 155 26.344 -21.491 17.959 0.60 25.69 C Unresolved disorder model. using A ATOM 1286 CG BGLN 155 26.600 -20.863 17.986 0.40 29.84 C Unresolved disorder model. using A ATOM 1287 CD AGLN 155 27.702 -20.873 18.218 0.60 29.15 C Unresolved disorder model. using A ATOM 1288 CD BGLN 155 26.565 -19.866 19.159 0.40 30.91 C Unresolved disorder model. using A ATOM 1289 OE1AGLN 155 28.751 -21.577 18.227 0.60 32.44 O Unresolved disorder model. using A ATOM 1290 OE1BGLN 155 25.871 -18.845 19.121 0.40 37.87 O Unresolved disorder model. using A ATOM 1291 NE2AGLN 155 27.706 -19.539 18.447 0.60 23.98 N Unresolved disorder model. using A ATOM 1292 NE2BGLN 155 27.353 -20.147 20.182 0.40 35.78 N Unresolved disorder model. using A ATOM 1397 N AVAL 170 22.179 -23.649 14.957 0.50 22.17 N Unresolved disorder model. using A ATOM 1398 N BVAL 170 22.146 -23.699 15.030 0.50 21.66 N Unresolved disorder model. using A ATOM 1399 CA AVAL 170 21.138 -22.827 15.583 0.50 20.89 C Unresolved disorder model. using A ATOM 1400 CA BVAL 170 21.030 -22.933 15.580 0.50 19.29 C Unresolved disorder model. using A ATOM 1401 C AVAL 170 21.041 -21.497 14.880 0.50 20.70 C Unresolved disorder model. using A ATOM 1402 C BVAL 170 21.007 -21.534 14.970 0.50 19.91 C Unresolved disorder model. using A ATOM 1403 O AVAL 170 22.058 -20.812 14.677 0.50 21.86 O Unresolved disorder model. using A ATOM 1404 O BVAL 170 22.053 -20.868 14.875 0.50 21.52 O Unresolved disorder model. using A ATOM 1405 CB AVAL 170 21.455 -22.496 17.062 0.50 23.78 C Unresolved disorder model. using A ATOM 1406 CB BVAL 170 21.006 -22.880 17.147 0.50 20.59 C Unresolved disorder model. using A ATOM 1407 CG1AVAL 170 20.329 -21.626 17.676 0.50 22.42 C Unresolved disorder model. using A ATOM 1408 CG1BVAL 170 22.233 -22.178 17.701 0.50 17.78 C Unresolved disorder model. using A ATOM 1409 CG2AVAL 170 21.608 -23.741 17.831 0.50 20.88 C Unresolved disorder model. using A ATOM 1410 CG2BVAL 170 19.721 -22.155 17.617 0.50 17.73 C Unresolved disorder model. using A ATOM 1478 CA AGLU 180 22.203 -34.548 12.235 0.50 21.03 C Unresolved disorder model. using A ATOM 1479 CA BGLU 180 22.192 -34.538 12.237 0.50 23.38 C Unresolved disorder model. using A ATOM 1482 CB AGLU 180 22.911 -34.504 10.866 0.50 20.05 C Unresolved disorder model. using A ATOM 1483 CB BGLU 180 22.914 -34.427 10.897 0.50 25.48 C Unresolved disorder model. using A ATOM 1484 CG AGLU 180 24.345 -33.938 10.841 0.50 17.01 C Unresolved disorder model. using A ATOM 1485 CG BGLU 180 22.111 -33.713 9.760 0.50 29.10 C Unresolved disorder model. using A ATOM 1486 CD AGLU 180 25.116 -34.076 9.465 0.50 19.56 C Unresolved disorder model. using A ATOM 1487 CD BGLU 180 20.877 -34.476 9.329 0.50 32.42 C Unresolved disorder model. using A ATOM 1488 OE1AGLU 180 24.566 -34.176 8.341 0.50 14.46 O Unresolved disorder model. using A ATOM 1489 OE1BGLU 180 20.864 -35.687 9.599 0.50 32.01 O Unresolved disorder model. using A ATOM 1490 OE2AGLU 180 26.357 -34.020 9.530 0.50 19.64 O Unresolved disorder model. using A ATOM 1491 OE2BGLU 180 19.921 -33.895 8.762 0.50 25.70 O Unresolved disorder model. using A ATOM 1609 CA ALYS 196 23.063 -28.645 3.314 0.50 18.54 C Unresolved disorder model. using A ATOM 1610 CA BLYS 196 23.055 -28.640 3.303 0.50 20.36 C Unresolved disorder model. using A ATOM 1613 CB ALYS 196 22.802 -29.890 4.169 0.50 17.33 C Unresolved disorder model. using A ATOM 1614 CB BLYS 196 22.742 -29.904 4.122 0.50 22.29 C Unresolved disorder model. using A ATOM 1615 CG ALYS 196 23.299 -31.201 3.494 0.50 18.11 C Unresolved disorder model. using A ATOM 1616 CG BLYS 196 22.891 -31.221 3.321 0.50 27.40 C Unresolved disorder model. using A ATOM 1617 CD ALYS 196 22.790 -32.456 4.248 0.50 15.78 C Unresolved disorder model. using A ATOM 1618 CD BLYS 196 22.593 -32.505 4.181 0.50 27.26 C Unresolved disorder model. using A ATOM 1619 CE ALYS 196 23.462 -32.618 5.581 0.50 13.61 C Unresolved disorder model. using A ATOM 1620 CE BLYS 196 21.094 -32.806 4.271 0.50 32.13 C Unresolved disorder model. using A ATOM 1621 NZ ALYS 196 22.800 -33.809 6.230 0.50 17.41 N Unresolved disorder model. using A ATOM 1622 NZ BLYS 196 20.693 -34.053 5.065 0.50 32.74 N Unresolved disorder model. using A ATOM 1696 CA AVAL 206 28.478 -19.200 10.830 0.50 22.55 C Unresolved disorder model. using A ATOM 1697 CA BVAL 206 28.411 -19.121 10.904 0.50 24.14 C Unresolved disorder model. using A ATOM 1700 CB AVAL 206 28.808 -20.493 10.043 0.50 19.83 C Unresolved disorder model. using A ATOM 1701 CB BVAL 206 28.445 -20.513 10.264 0.50 24.47 C Unresolved disorder model. using A ATOM 1702 CG1AVAL 206 29.182 -21.690 10.994 0.50 18.81 C Unresolved disorder model. using A ATOM 1703 CG1BVAL 206 29.748 -20.717 9.546 0.50 22.06 C Unresolved disorder model. using A ATOM 1704 CG2AVAL 206 27.623 -20.871 9.118 0.50 16.30 C Unresolved disorder model. using A ATOM 1705 CG2BVAL 206 28.223 -21.616 11.344 0.50 21.94 C Unresolved disorder model. using A ATOM 1717 CA ATHR 208 31.951 -22.375 14.281 0.50 21.73 C Unresolved disorder model. using A ATOM 1718 CA BTHR 208 32.003 -22.341 14.254 0.50 23.29 C Unresolved disorder model. using A ATOM 1721 CB ATHR 208 33.225 -22.715 13.543 0.50 23.46 C Unresolved disorder model. using A ATOM 1722 CB BTHR 208 33.295 -22.438 13.456 0.50 29.08 C Unresolved disorder model. using A ATOM 1723 OG1ATHR 208 34.292 -21.895 14.037 0.50 21.46 O Unresolved disorder model. using A ATOM 1724 OG1BTHR 208 33.103 -21.724 12.212 0.50 33.02 O Unresolved disorder model. using A ATOM 1725 CG2ATHR 208 33.041 -22.526 12.003 0.50 24.99 C Unresolved disorder model. using A ATOM 1726 CG2BTHR 208 33.679 -23.867 13.149 0.50 27.19 C Unresolved disorder model. using A ATOM 1793 CA ATHR 218 37.344 -28.647 3.924 0.50 22.96 C Unresolved disorder model. using A ATOM 1794 CA BTHR 218 37.322 -28.655 3.933 0.50 26.50 C Unresolved disorder model. using A ATOM 1797 CB ATHR 218 37.035 -30.128 4.207 0.50 21.68 C Unresolved disorder model. using A ATOM 1798 CB BTHR 218 36.867 -30.118 4.238 0.50 29.51 C Unresolved disorder model. using A ATOM 1799 OG1ATHR 218 38.204 -30.910 3.897 0.50 23.03 O Unresolved disorder model. using A ATOM 1800 OG1BTHR 218 37.061 -30.410 5.630 0.50 40.74 O Unresolved disorder model. using A ATOM 1801 CG2ATHR 218 35.843 -30.628 3.424 0.50 17.64 C Unresolved disorder model. using A ATOM 1802 CG2BTHR 218 37.639 -31.139 3.410 0.50 32.47 C Unresolved disorder model. using A ATOM 1881 CA ALYS 229 31.543 -15.987 6.377 0.50 28.65 C Unresolved disorder model. using A ATOM 1882 CA BLYS 229 31.550 -15.970 6.381 0.50 28.60 C Unresolved disorder model. using A ATOM 1885 CB ALYS 229 31.265 -14.557 6.776 0.50 31.15 C Unresolved disorder model. using A ATOM 1886 CB BLYS 229 31.299 -14.515 6.781 0.50 31.35 C Unresolved disorder model. using A ATOM 1887 CG ALYS 229 31.389 -13.595 5.639 0.50 32.04 C Unresolved disorder model. using A ATOM 1888 CG BLYS 229 32.468 -13.819 7.533 0.50 31.94 C Unresolved disorder model. using A ATOM 1889 CD ALYS 229 31.137 -12.196 6.157 0.50 39.76 C Unresolved disorder model. using A ATOM 1890 CD BLYS 229 32.293 -12.300 7.455 0.50 39.64 C Unresolved disorder model. using A ATOM 1891 CE ALYS 229 30.718 -11.300 5.032 0.50 43.21 C Unresolved disorder model. using A ATOM 1892 CE BLYS 229 33.493 -11.579 8.033 0.50 45.18 C Unresolved disorder model. using A ATOM 1893 NZ ALYS 229 29.532 -10.584 5.549 0.50 42.90 N Unresolved disorder model. using A ATOM 1894 NZ BLYS 229 33.648 -12.080 9.427 0.50 49.41 N Unresolved disorder model. using A ATOM 2042 CA ALYS 249 20.349 -30.241 27.858 0.50 39.59 C Unresolved disorder model. using A ATOM 2043 CA BLYS 249 20.394 -30.358 27.791 0.50 40.65 C Unresolved disorder model. using A ATOM 2046 CB ALYS 249 20.363 -29.329 29.111 0.50 38.13 C Unresolved disorder model. using A ATOM 2047 CB BLYS 249 20.622 -29.813 29.220 0.50 45.81 C Unresolved disorder model. using A ATOM 2048 CG ALYS 249 19.475 -29.776 30.277 0.50 37.82 C Unresolved disorder model. using A ATOM 2049 CG BLYS 249 22.077 -29.988 29.717 0.50 44.58 C Unresolved disorder model. using A ATOM 2050 CD ALYS 249 19.918 -29.158 31.631 0.50 30.41 C Unresolved disorder model. using A ATOM 2051 CD BLYS 249 22.188 -30.103 31.257 0.50 48.96 C Unresolved disorder model. using A ATOM 2052 CE ALYS 249 19.236 -29.912 32.792 0.50 38.79 C Unresolved disorder model. using A ATOM 2053 CE BLYS 249 23.499 -30.793 31.649 0.50 45.24 C Unresolved disorder model. using A ATOM 2054 NZ ALYS 249 19.880 -29.699 34.129 0.50 43.03 N Unresolved disorder model. using A ATOM 2055 NZ BLYS 249 23.392 -31.587 32.924 0.50 51.73 N Unresolved disorder model. using A ATOM 2065 N ALEU 251 17.665 -30.491 24.287 0.70 34.33 N Unresolved disorder model. using A ATOM 2066 N BLEU 251 17.669 -30.446 24.290 0.30 28.05 N Unresolved disorder model. using A ATOM 2067 CA ALEU 251 17.572 -31.434 23.165 0.70 31.01 C Unresolved disorder model. using A ATOM 2068 CA BLEU 251 17.641 -31.356 23.147 0.30 24.38 C Unresolved disorder model. using A ATOM 2069 C ALEU 251 17.637 -32.844 23.655 0.70 30.14 C Unresolved disorder model. using A ATOM 2070 C BLEU 251 17.675 -32.796 23.625 0.30 25.55 C Unresolved disorder model. using A ATOM 2071 O ALEU 251 16.871 -33.718 23.228 0.70 27.30 O Unresolved disorder model. using A ATOM 2072 O BLEU 251 16.879 -33.617 23.177 0.30 25.38 O Unresolved disorder model. using A ATOM 2073 CB ALEU 251 18.740 -31.243 22.195 0.70 36.44 C Unresolved disorder model. using A ATOM 2074 CB BLEU 251 18.829 -31.090 22.209 0.30 20.57 C Unresolved disorder model. using A ATOM 2075 CG ALEU 251 18.419 -30.415 20.967 0.70 40.93 C Unresolved disorder model. using A ATOM 2076 CG BLEU 251 18.967 -32.015 20.997 0.30 15.84 C Unresolved disorder model. using A ATOM 2077 CD1ALEU 251 19.609 -30.337 20.028 0.70 39.47 C Unresolved disorder model. using A ATOM 2078 CD1BLEU 251 17.729 -31.998 20.201 0.30 14.63 C Unresolved disorder model. using A ATOM 2079 CD2ALEU 251 17.170 -30.998 20.246 0.70 33.09 C Unresolved disorder model. using A ATOM 2080 CD2BLEU 251 20.124 -31.549 20.100 0.30 16.29 C 1